The Billion-Dollar Molecule

From Wikipedia, the free encyclopedia
Jump to: navigation, search
The Billion-Dollar Molecule
The Billion Dollar Molecule-large.jpg
Paperback edition
Author Barry Werth
Country United States
Language English
Subject Biotechnology
Genre Non-fiction
Publisher Simon & Schuster
Publication date
February 16, 1994
Pages 448 pp. (hardcover)
ISBN 0-671-51057-6

The Billion-Dollar Molecule is a book[1] by journalist Barry Werth about the founding and early research efforts of the American biotechnology company Vertex Pharmaceuticals, which was founded in 1989 by Joshua Boger and was among the first biotechnology companies to adopt an explicit strategy of rational drug design as opposed to techniques based on combinatorial chemistry.

This book is notable as an inside look at a biotechnology company, and the stresses and marketing pressures on funding research into drug design. This book is a mixture of finance and technology.

In February, 2014, Barry Werth published a follow-on book, The Antidote,[2] that looks at Vertex 20 years later after his original effort.[3]

References[edit]

  1. ^ Barry Werth (February 16, 1994), The Billion-Dollar Molecule: The Quest for the Perfect Drug, Simon & Schuster, p. 448, ISBN 0671510576 
  2. ^ Barry Werth (December 2014). The Antidote Inside the World of New Pharma. Simon & Schuster. p. 448. ISBN 9781451655674. Retrieved July 19, 2015. 
  3. ^ http://www.barrywerth.com retrieved 2014-01-01